Syntal Capital Partners’s Bausch Health BHC Stock Holding History

Syntal Capital Partners’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-7,873	Closed	-$202K	–	110
2019 Q3	$202K	Hold	7,873	–	–	0.05%	198
2019 Q2	$202K	Buy	+7,873	New	+$187K	0.04%	239
2016 Q1	–	Sell	-311	Closed	-$55K	–	63
2015 Q4	$55K	Hold	311	–	–	0.06%	64
2015 Q3	$55K	Hold	311	–	–	0.08%	77
2015 Q2	$69	Hold	311	–	–	0.07%	90
2015 Q1	$61K	Hold	311	–	–	0.08%	90
2014 Q4	$44K	Hold	311	–	–	0.03%	121
2014 Q3	$40K	Hold	311	–	–	0.02%	127
2014 Q2	$39K	Buy	+311	New	+$39.7K	0.02%	140

Other funds holding BHC

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Syntal Capital Partners's BHC Position: Q4 2019 in Review

Syntal Capital Partners sold out of Bausch Health (BHC) in Q4 2019, closing a stake of 7,873 shares — an estimated $202K sold.

Syntal Capital Partners first reported a position in BHC in Q2 2014 and held it in 9 quarters. The position peaked at $202K in Q3 2019. 327 funds tracked by Wall St. Rank hold BHC as of Q4 2019.

Syntal Capital Partners reported no remaining Bausch Health position as of Q4 2019 after selling out during the quarter.
Syntal Capital Partners sold 7,873 Bausch Health shares in Q4 2019, an estimated $202K.
Syntal Capital Partners first reported a position in Bausch Health in Q2 2014 and held it in 9 quarters.
Syntal Capital Partners's Bausch Health position peaked at $202K in Q3 2019.
327 funds tracked by Wall St. Rank held Bausch Health as of Q4 2019.

Based on Syntal Capital Partners's 13F filing for Q4 2019, filed 10 Feb 2020.